⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 23, 2006European Journal of Heart Failure

Clinical Trials Update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and Percutaneous Mitral Annuloplasty

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

John G.F. ClelandHeart Failure / Cardiomyopathy ACA ColettaUniversity of Hull AAAhmed Tageldien AbdellahSuez Canal University

Discussion

Loading...

Member takes

Implication

These preliminary summaries leave practice unchanged; they extend the research pipeline pending full peer-reviewed trial reports.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cleland et al. (2006) studied this question.

synapsesocial.com/papers/6a71236e660549caf2c5c5bc https://doi.org/10.1016/j.ejheart.2006.12.001

Topics

Persistent AF management Cardiomyopathy Atrial fibrillation AF ablation outcomes Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical Trials Update from the American Heart Association Meeting: Ω-3 Fatty Acids and Arrhythmia Risk in Patients with an Implantable Defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE2004 · 36 citations
2Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions1998 · 228 citations
3Percutaneous Transvenous Mitral Annuloplasty2006 · 252 citations
4The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure2005 · 6,311 citations
5Clinical Trials Update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE2005 · 320 citations